Connecting Today and Tomorrow

  • Performance
  • Project Experience

Project Experience

Annual Study Performance

Number of Studies (2021 - 2025) 5,809
Annual Study Performance

Number of Studies by Substance

Number of Studies by Substance

Studies Contributing to IND and NDA Submissions

  • in Korea, China, and
    Southeast Asia

    Over 60 Cases

  • US FDA

    20 Cases

  • EMA

    1 Case

  • Australia

    4 Cases

  • First Korean
    Biological Drug

  • First Korean
    Botanical Drug

  • CNS drug, analgesic
    related drug,
    COPD drug, Botox etc

Promotional Video Contact Us